Us2.ai
Singapore, Singapore
Us2.ai uses machine learning to improve clinical decision making and cardiovascular research for clinical trials using echocardiography. Us2.ai connects institutions and imaging labs on a platform of ready-to-use automation tools for view classification, segmentation and federated learning across diverse, anonymous patient and disease cohorts.
Company Info
- Founded
- 2017
- Website
- us2.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Us2.ai?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment